FunPep is a biotechnology venture company focused on development of functional peptides derived from the platform technology of graduate school of medicine, Osaka University. FunPep is planning a wide range of business development such as cosmetic, medical devices, regenerative medicine and ethical drug by taking advantage of its technology.
The investigator initiated clinical trial for SR-0379 was completed in 2017, with leg ulcer and diabetic skin ulcer in phase I/IIa.
The outline is referred to followings:
◆University hospital Medical Information Network (UMIN) Center
◆National Institute of Public Health